Impax Laboratories to Present at the 25th Annual Piper Jaffray Healthcare Conference on December 3

November 27, 2013

HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that Bryan M. Reasons, chief financial officer, and Carole S. Ben-Maimon, M.D., president of Global Pharmaceuticals (Impax’s generics division) will present at the Piper Jaffray Healthcare Conference on Tuesday, December 3, at 9:00 a.m. Eastern Standard Time. The conference will be held in New York, NY.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company’s web site at This presentation will be archived on the Company’s web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at:

Source: Impax Laboratories, Inc.

Company Contact:

Impax Laboratories, Inc.

Mark Donohue

Investor Relations and Corporate Communications